Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca to invest $300 million in US facility for cell therapies
Reuters
Tue, 02/6/24 - 11:38 pm
Tags:
AstraZeneca, cell therapy
AstraZeneca's phase 3 heart disease trial hits, teeing up Pfizer showdown in Japan
Fierce Biotech
Fri, 02/2/24 - 11:53 am
Tags:
AstraZeneca, Pfizer, acoramidis, Japan, clinical trials, cardiomyopathy, ATTR-CM
AstraZeneca Case Leads Off Busy Year of Challenges to Medicare Drug Pricing Law
BioSpace
Thu, 02/1/24 - 10:51 pm
Tags:
AstraZeneca, legal, Inflattion Reduction Act, Medicare, drug pricing
Sanofi expects RSV antibody to ⁠breach blockbuster status in 2024, even as supply hitch drags on
Fierce Pharma
Thu, 02/1/24 - 11:33 am
Tags:
Sanofi, RSV, AstraZeneca, Beyfortus
Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC
Fierce Pharma
Wed, 01/31/24 - 10:27 pm
Tags:
Daiichi Sankyo, AstraZeneca, Enhertu, earnings
As AstraZeneca gears up for courtroom showdown over IRA, Novo's case faces separate HHS rebuke
Fierce Pharma
Tue, 01/30/24 - 09:26 pm
Tags:
AstraZeneca, Novo Nordisk, legal, Inflation Reduction Act, HHS, drug pricing
AstraZeneca, Daiichi aim for first pan-tumor ADC approval
BioPharma Dive
Mon, 01/29/24 - 11:25 am
Tags:
AstraZeneca, Daiichi Sankyo, antibody-drug conjugate, Enhertu, pan-tumor, FDA
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Fierce Biotech
Wed, 01/24/24 - 10:35 am
Tags:
Synnovation Therapeutics, Incyte, AstraZeneca, GSK, Novartis, Pfizer, funding, cancer, PARP inhibitors
AstraZeneca reports positive data from Phase III trial of Imfinzi
Clinical Trials Arena
Mon, 01/22/24 - 11:29 am
Tags:
AstraZeneca, Imfinzi, clinical trials, hepatocellular carcinoma
BioNTech challenges AstraZeneca with breast cancer precision drug trial
Reuters
Mon, 01/22/24 - 11:15 am
Tags:
BioNTech, Duality Biologics, clinical trials, breast cancer, AstraZeneca, Daiichi Sankyo, HER2+ breast cancer
AZ bags first approval for PNH therapy danicopan, in Japan
Pharmaphorum
Fri, 01/19/24 - 09:38 am
Tags:
AstraZeneca, Voydeya, PNH, danicopan
IRA lawsuits will be vital test of US’ ability to regulate pharma market
Clinical Trials Arena
Wed, 01/17/24 - 09:41 am
Tags:
legal, Inflation Reduction Act, JNJ, AstraZeneca, HHS, drug pricing
Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference
Reuters
Fri, 01/5/24 - 11:25 am
Tags:
M&A, JPMHC 2024, AbbVie, AstraZeneca, Bristol Myers Squibb, Carmot Therapeutics, Eli Lilly
AstraZeneca picks up a friend for Tagrisso in $40M upfront deal
Fierce Biotech
Tue, 01/2/24 - 10:05 pm
Tags:
AstraZeneca, Allorion Therapeutics, lung cancer, Tagrisso
Biopharma Closes 2023 with Flurry of M&A Activity from AstraZeneca, BMS, Roche
BioSpace
Tue, 01/2/24 - 11:26 am
Tags:
M&A, AstraZeneca, Gracell Biotechnologies, Bristol Myers Squibb, Rayze Bio, Roche
AZ, Sanofi’s Beyfortus cleared in China for RSV prevention
Pharmaphorum
Tue, 01/2/24 - 10:09 am
Tags:
AstraZeneca, Sanofi, Beyfortus, RSV, vaccines, China
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
BioSpace
Wed, 12/27/23 - 11:08 pm
Tags:
AstraZeneca, Gracell, cell therapy, M&A
FDA approves Ionis-AstraZeneca's nerve disease drug
Reuters
Fri, 12/22/23 - 09:42 am
Tags:
Ionis Pharmaceuticals, AstraZeneca, FDA, Wainua, ATTR-PN
AstraZeneca, Sanofi to supply 230,000 more RSV infant shots to US market
Reuters
Thu, 12/14/23 - 10:48 pm
Tags:
RSV, vaccines, Sanofi, AstraZeneca
AstraZeneca Buys into RSV Vaccine Market with Potential $1.1B Icosavax Purchase
BioSpace
Tue, 12/12/23 - 11:17 am
Tags:
AstraZeneca, Icosavax, RSV, M&A, vaccines

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.